Moore N, Chadelaud M, Gügi B, Saligaut C, Berland C, Chrétien P, Daoust M, Boismare F
Clin Exp Hypertens A. 1983;5(4):613-24. doi: 10.3109/10641968309081796.
Six consanguine monogamous SHR couples (G1) were treated from 5 weeks of age on with an alpha blocker, nicergoline, 0.1 mg/kg/day i.p.. Male rats were treated without interruption; treatment was withheld in female rats from delivery to weaning. They were compare to six similar SHR couples who were only daily i.p. injected with the same volume of solvent in the same conditions as controls, as well as with naive (untreated) rats. Second (G2) and third (G3) generation rats (untreated) were studied. In G1 rats, systolic blood pressure (SBP), heart rate, heart weight/body weight ratio and bulbar noradrenaline content were decreased (compared to control or naive rats), while plasma renin activity (PRA) and hypothalamic noradrenaline content were not changed. In G2 rats, SBP and PRA were decreased, all other parameters being unchanged. No parameter was changed in G3 rats. This appears to be the first report of a preventive effect of antenatal treatment on the development of hypertension in SHR.
六对近亲一夫一妻制的自发性高血压大鼠(SHR)夫妇(G1组)从5周龄开始接受α受体阻滞剂尼麦角林治疗,腹腔注射剂量为0.1mg/kg/天。雄性大鼠不间断接受治疗;雌性大鼠从分娩至断奶期间停止治疗。将它们与六对类似的SHR夫妇进行比较,后者在相同条件下每天腹腔注射相同体积的溶剂作为对照,同时与未经处理的(未治疗的)大鼠进行比较。对第二代(G2组)和第三代(G3组)大鼠(未治疗)进行了研究。在G1组大鼠中,收缩压(SBP)、心率、心脏重量/体重比和延髓去甲肾上腺素含量降低(与对照或未治疗大鼠相比),而血浆肾素活性(PRA)和下丘脑去甲肾上腺素含量未改变。在G2组大鼠中,SBP和PRA降低,所有其他参数均未改变。G3组大鼠的任何参数均未改变。这似乎是关于产前治疗对SHR高血压发展具有预防作用的首次报道。